AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
On Sunday, Margaret Foti, PhD, MD (hc), chief executive officer of the AACR, met with the president of Israel,...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the bone marrow and the blood that develops in either...
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
Editor’s note: Progress and Promise Against Cancer is the AACR’s initiative to educate the public about cancer and cancer...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...
Today, September 24, 2018, is World Cancer Research Day. The American Association for Cancer Research (AACR) is proud to...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...